发明公开
EP2255811A1 Mequitazine for treating or preventing pathologies involving histamine H4 receptors
审中-公开
美喹他嗪，涉及组胺H4受体治疗或预防疾病
- 专利标题： Mequitazine for treating or preventing pathologies involving histamine H4 receptors
- 专利标题（中）： 美喹他嗪，涉及组胺H4受体治疗或预防疾病
-
申请号： EP10177151.7申请日： 2008-12-04
-
公开(公告)号： EP2255811A1公开(公告)日： 2010-12-01
- 发明人: Clerc, Thierry , Przybylski, Christophe , Tisne-Versailles, Jacky , Cussac, Didier
- 申请人： PIERRE FABRE MEDICAMENT
- 申请人地址： 45, Place Abel Gance 92100 Boulogne-Billancourt FR
- 专利权人： PIERRE FABRE MEDICAMENT
- 当前专利权人： PIERRE FABRE MEDICAMENT
- 当前专利权人地址： 45, Place Abel Gance 92100 Boulogne-Billancourt FR
- 代理机构： Ahner, Francis
- 优先权： FR0759538 20071204; FR0854144 20080623
- 主分类号： A61K31/5415
- IPC分类号： A61K31/5415 ; A61P17/00 ; A61P17/04
摘要：
The present application relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10 H -phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10 H -phenothiazine or 10-[(3R,3S)-1-azabicycio[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or a pharmaceutically acceptable salt thereof, to prepare a drug to prevent or treat pathologies involving histamine H4 receptor, chosen among atopic dermatitis and pruritus.
信息查询
IPC分类:
